Hemostatic treatment in the early stage of intracerebral hemorrhage: the recombinant factor VIIa experience.
Kase
Carlos S
CS
Department of Neurology, Boston University School of Medicine, Boston, MA 02118, USA. cskase@bu.edu
D002543:Cerebral Hemorrhage / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D015942:Factor VIIa / Q000627:therapeutic use*; D006489:Hemostatic Techniques; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use*; D016896:Treatment Outcome
D006490:Hemostatics; D011994:Recombinant Proteins; D015942:Factor VIIa